PATENT CLAIM ANALYSIS

Application Number: 16103375
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "253130"]

Abstract:
The disclosure provides compounds of Formulae (I)-(IX). The disclosed compounds are capable of inhibiting a mammalian SHMT. Compounds of the disclosure have numerous uses, such as for treatment of cancer or autoimmue disorders.

Claim (Index 4):
The method according to  claim 2 , wherein R 13 , R 14 , and R 15  are independently selected from the group consisting of hydrogen, \u2014OH, halogen, optionally substituted alkyl, optionally substituted haloalkyl, \u2014OR a , \u2014OC(O)R b , \u2014C(O)NR a R b , and \u2014NR a R b , wherein R a  and R b , independently at each occurrence, are H or optionally substituted alkyl.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.30303
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15705200', '15552442', '14346359', '13891067', '13227130']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8248525799576247
- 35 USC 102 Novelty (BERT): 0.6808840011100289
- Combined Prediction Score: 0.8104557220728652
- Mean Citation Score: 448.057326
- Max Citation Score: 794.0231
- Similarity Product: 657.7340102509976

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test